單細胞分析市場 - 全球產業規模、佔有率、趨勢、機會、預測：按產品、技術、細胞類型、應用、最終用戶、地區和競爭格局分類，2021-2031年

全球單細胞分析市場預計將從 2025 年的 43.8 億美元大幅成長至 2031 年的 82.9 億美元，複合年成長率為 11.22%。

該市場涵蓋了能夠分離和全面分析單一細胞的技術，從而揭示傳統組織整體分析中常被忽略的基因組和蛋白質組異質性。推動該領域成長的關鍵因素包括慢性疾病（尤其是癌症）發病率的上升，以及對依賴詳細細胞分析來識別治療標靶的個人化醫療日益成長的需求。美國癌症協會預測，到2024年美國將新增超過200萬例癌症病例，這進一步凸顯了單細胞分析工作流程所提供的精準診斷能力的重要性。

儘管單細胞分析市場發展前景良好，但仍面臨許多挑戰，主要原因在於設備高成本以及試劑的累積成本。這些經濟障礙限制了小規模研究機構和臨床機構對該技術的採用。此外，管理和解讀多維資料本身就具有很高的複雜性，這帶來了巨大的技術挑戰，阻礙了不同平台間的標準化。這些經濟和計算方面的難題共同構成了阻礙單細胞分析廣泛應用的主要障礙，限制了其從學術研究到常規臨床實踐的轉化。

市場促進因素

空間體學和高通量定序的快速發展顯著推動了市場擴張，從根本上改變了研究人員探索基因組異質性的方式。這些創新技術能夠繪製活體組織固有結構內的基因表現圖譜，從而深入了解以往基於懸浮液培養方法無法實現的細胞間相互作用。這種解析度的提升對於深入理解複雜的生物網路和疾病進展至關重要。例如，正如惠康桑格研究所於2024年11月宣布的那樣，國際研究人員利用這些先進技術建構了一個涵蓋多種組織中6,200萬個細胞的綜合生物圖譜——這是人類細胞圖譜計畫的一個重要里程碑。這種高通量能力能夠產生海量、多維度資料集，這對於識別新的生物標記至關重要，並進一步提升了單細胞工作流程在基礎研究和轉化研究中的效用。

同時，創業投資的大幅成長正在加速基因組技術向實用藥物研發平台的轉型。投資者擴大投資於利用單細胞數據闡明疾病機制的公司，他們認知到這些詳細資訊對於開發精準醫療和降低臨床試驗失敗率至關重要。 Relation Therapeutics 於 2024 年 3 月成功獲得 6,000 萬美元種子輪資金籌措，用於擴展其專注於藥物研發的整合式濕實驗室和計算平台，就是一個顯著的例子。這筆資金的流入正在推動建立強大的研發管線，並改善這些技術的可及性。然而，該領域仍然依賴現有的基礎設施。正如 10x Genomics 2024 年第三季 1.517 億美元的銷售額所表明的那樣，儘管新的競爭對手不斷湧現，但作為生命科學經濟的關鍵組成部分，對基礎單細胞分析儀器的需求仍然強勁。

市場挑戰

單細胞分析儀的累積成本，加上試劑的累積成本，構成了一道巨大的經濟壁壘，嚴重限制了其市場擴充性。這種資本密集特性造成了不平等，使得這些先進技術的充分利用主要局限於資金雄厚的大型製藥公司和頂尖學術研究機構。因此，小規模實驗室和臨床機構面臨著沉重的成本負擔，阻礙了將專門的藥物研發工具——單細胞工作流程——整合到標準診斷程序中。除非找到有效的方法來分攤這些巨額的初始成本，否則醫療保健行業的採用率將繼續受到嚴重抑制。

此外，目前的投資趨勢表明，克服這些重大採購障礙所需的資金嚴重短缺。根據生技創新組織（BIO）預測，2025年生技新創公司的資金籌措將大幅下降，從第一季的26億美元驟降至第二季的9億美元。流動性的萎縮直接阻礙了市場成長，降低了通常引領創新的新興企業的購買力。隨著企業融資管道的減少，它們部署昂貴的單細胞平台的能力也隨之下降，最終導致整體市場擴張放緩。

市場趨勢

無需儀器的單細胞分離技術的出現，從根本上改變了市場准入格局，因為它消除了對高成本硬體的需求。由於無需昂貴的控制器和微流體儀器，這一趨勢有效地普及了先進的基因組分析工作流程，使以往經濟上難以負擔的單細胞技術能夠惠及小規模實驗室和區域中心。因此，向更容易使用的試劑盒解決方案的轉變正在加速基因組研究的去中心化。例如，2025年3月，Parse Biosciences宣布與南澳大利亞基因組中心建立合作關係，成為其授權服務供應商。該公司正在部署無需儀器的Evercode技術，以擴大全部區域高通量分析的覆蓋範圍，而無需承擔安裝專用硬體所帶來的後勤負擔。

同時，單細胞分析技術正拓展至神經科學和免疫學等非腫瘤領域，使市場收入來源不再侷限於傳統的癌症研究。研究人員擴大利用單細胞層級分析來揭示自體免疫疾病背後複雜的免疫異質性，並揭示神經系統疾病的細胞結構。這一戰略轉變將使該行業能夠應對更廣泛的病理，而批量定序方法往往無法捕捉關鍵的細胞亞群。一個顯著的例子是，瑞士創新署（Innosuisse）於2025年11月向Scailyte公司授予80萬瑞士法郎的津貼，用於將其單細胞分析平台應用於發炎性腸道疾病的精準醫療。這凸顯了在腫瘤以外的免疫學適應症中利用這些技術日益成長的商業性和臨床重要性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球單細胞分析市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品分類（耗材、設備）
  • 透過技術手段（流式細胞技術、次世代定序、PCR、顯微鏡、質譜分析及其他技術）
  • 細胞類型（人類、微生物、動物）
  • 按應用領域（研究領域、醫學領域）
  • 依最終用戶分類（學術機構/研究機構、生物技術/製藥公司、醫院/診斷檢測實驗室、細胞庫/體外受精中心）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美單細胞分析市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲單細胞分析市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太單細胞分析市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲單細胞分析市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲單細胞分析市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章 全球單細胞分析市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Thermo Fisher Scientific Inc.
• Qiagen NV
• Danaher Corporation
• Becton, Dickinson and Company.
• Merck KGaA
• 10X Genomics
• Takara Bio Inc.
• Standard BioTools Inc.
• Bio-Rad Laboratories Inc.
• Illumina Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Single Cell Analysis Market is projected to expand significantly, growing from USD 4.38 Billion in 2025 to USD 8.29 Billion by 2031, reflecting an 11.22% compound annual growth rate. This market encompasses technologies that allow for the isolation and comprehensive characterization of individual cells, thereby revealing genomic and proteomic heterogeneity that is often obscured by traditional bulk tissue analysis. Key drivers for this sector's growth include the increasing incidence of chronic diseases, particularly cancer, and the escalating demand for personalized medicine, which relies on granular cellular profiling to pinpoint therapeutic targets. This demand is further highlighted by the American Cancer Society's projection of over 2 million new cancer diagnoses in the United States in 2024, emphasizing the crucial need for the precise diagnostic capabilities offered by single cell workflows.

Despite this promising growth trajectory, the market faces considerable obstacles, primarily due to the high cost of instruments and the cumulative expenses of reagents. These financial barriers limit adoption in smaller research institutions and clinical environments. Moreover, the inherent complexity involved in managing and interpreting multi-dimensional data poses significant technical challenges, hindering standardization across diverse platforms. These combined financial and computational difficulties represent the main impediments that could prevent the widespread adoption of single cell analysis, restricting its transition from academic research into routine clinical practice.

Market Driver

Rapid advancements in spatial omics and high-throughput sequencing are significantly fueling market expansion, fundamentally transforming how researchers investigate genomic heterogeneity. These innovative technologies now facilitate the mapping of gene expression within its native tissue architecture, providing insights into cellular interactions previously unobtainable with suspension-based methods. This enhanced resolution is critical for a deeper understanding of complex biological networks and disease progression. For example, as announced by the Wellcome Sanger Institute in November 2024, international researchers utilized these advanced capabilities to compile a comprehensive biological atlas profiling 62 million cells across various tissues, marking a major milestone for the Human Cell Atlas. Such high-throughput capacity enables the generation of vast, multi-dimensional datasets essential for identifying novel biomarkers, thus augmenting the utility of single cell workflows in both fundamental and translational research.

Concurrently, a substantial rise in venture capital investments is accelerating the translation of these genomic technologies into practical drug discovery platforms. Investors are increasingly channeling funds into companies that leverage single cell data to elucidate disease mechanisms, recognizing this granular information as vital for developing precision therapeutics and mitigating clinical trial failure rates. A notable instance of this financial confidence occurred in March 2024, when Relation Therapeutics secured $60 million in seed financing to scale its integrated wet-lab and computational platform specifically for drug development. This capital influx supports the creation of robust pipelines, enhancing the accessibility of these technologies. Nevertheless, the sector continues to rely on established infrastructure, as evidenced by 10x Genomics' 2024 report of $151.7 million in third-quarter revenue, demonstrating the persistent demand for foundational single cell instrumentation as a crucial element of the life sciences economy, despite emerging competition.

Market Challenge

The prohibitive cost of single cell analysis instruments, coupled with substantial cumulative expenses for reagents, constitutes a significant financial barrier that severely constrains market scalability. This capital-intensive nature creates a disparity, limiting the full utilization of these advanced technologies primarily to well-funded large pharmaceutical companies and elite academic centers. Consequently, smaller research laboratories and clinical settings are often priced out, preventing the integration of single cell workflows from specialized discovery tools into standard diagnostic procedures. Without the ability to effectively amortize these considerable upfront costs, the rate of adoption across the broader healthcare landscape remains significantly suppressed.

Furthermore, current investment trends indicate a tightening of capital essential for overcoming these substantial purchasing hurdles. According to the Biotechnology Innovation Organization, biotech startup funding saw a steep decline in 2025, plummeting from $2.6 billion in the first quarter to $900 million in the second quarter. This contraction in available liquidity directly impedes market growth by diminishing the purchasing power of emerging entities, which typically drive innovation. As organizations face reduced access to capital, their capacity to acquire expensive single cell platforms diminishes, consequently slowing the overall expansion of the market.

Market Trends

The emergence of instrument-free single-cell isolation techniques is fundamentally reshaping market access by removing the necessity for capital-intensive hardware. By eliminating the demand for expensive controllers and microfluidic instrumentation, this trend effectively democratizes advanced genomic workflows, enabling smaller laboratories and regional centers to adopt single cell technologies that were previously financially inaccessible. This shift towards more accessible, kit-based solutions is accelerating the decentralization of genomic research. For instance, in March 2025, Parse Biosciences announced its partnership with the South Australian Genomics Centre as a certified service provider, deploying its instrument-free Evercode technology to broaden high-throughput access across the Asia-Pacific region without the logistical burden of proprietary hardware installations.

Simultaneously, the expansion of single cell analysis into non-oncology fields, such as neuroscience and immunology, is diversifying the market's revenue base beyond its traditional focus on cancer. Researchers are increasingly applying single cell resolution to unravel the complex immune heterogeneity underlying autoimmune disorders and to delineate the cellular architecture of neurological conditions. This strategic pivot allows the industry to address a wider spectrum of pathologies where bulk sequencing methods often fail to capture critical cellular subsets. A notable illustration of this broadening application occurred in November 2025, when Scailyte secured an CHF 800,000 Innosuisse Grant to apply its single-cell analysis platform toward precision medicine in Inflammatory Bowel Disease, highlighting the growing commercial and clinical imperative to leverage these technologies for immunological indications beyond oncology.

Key Market Players

• Thermo Fisher Scientific Inc.
• Qiagen N.V.
• Danaher Corporation
• Becton, Dickinson and Company.
• Merck KGaA
• 10X Genomics
• Takara Bio Inc.
• Standard BioTools Inc.
• Bio-Rad Laboratories Inc.
• Illumina Inc.

Report Scope

In this report, the Global Single Cell Analysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Single Cell Analysis Market, By Product

• Consumables
• Instruments

Single Cell Analysis Market, By Technique

• Flow cytometry
• Next Generation Sequencing
• PCR
• Microscopy
• Mass Spectrometry
• Other techniques

Single Cell Analysis Market, By Cell Type

• Human
• Microbial
• Animal

Single Cell Analysis Market, By Application

• Research Field
• Medical Field

Single Cell Analysis Market, By End User

• Academic & Research laboratories
• Biotechnology & Pharmaceutical companies
• Hospital & diagnostic laboratories
• Cell banks & IVF Centers

Single Cell Analysis Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Single Cell Analysis Market.

Available Customizations:

Global Single Cell Analysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Single Cell Analysis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables, Instruments)
  • 5.2.2. By Technique (Flow cytometry, Next Generation Sequencing, PCR, Microscopy, Mass Spectrometry, Other techniques)
  • 5.2.3. By Cell Type (Human, Microbial, Animal)
  • 5.2.4. By Application (Research Field, Medical Field)
  • 5.2.5. By End User (Academic & Research laboratories, Biotechnology & Pharmaceutical companies, Hospital & diagnostic laboratories, Cell banks & IVF Centers)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Single Cell Analysis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technique
  • 6.2.3. By Cell Type
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Single Cell Analysis Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Cell Type
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Single Cell Analysis Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Cell Type
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Single Cell Analysis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Cell Type
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Single Cell Analysis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technique
  • 7.2.3. By Cell Type
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Single Cell Analysis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Cell Type
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. France Single Cell Analysis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Cell Type
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Single Cell Analysis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Cell Type
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Single Cell Analysis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Cell Type
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Single Cell Analysis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Cell Type
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia Pacific Single Cell Analysis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technique
  • 8.2.3. By Cell Type
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Single Cell Analysis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Cell Type
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Single Cell Analysis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Cell Type
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Single Cell Analysis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Cell Type
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Single Cell Analysis Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Cell Type
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Single Cell Analysis Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Cell Type
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. Middle East & Africa Single Cell Analysis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technique
  • 9.2.3. By Cell Type
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Single Cell Analysis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Cell Type
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Single Cell Analysis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Cell Type
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Single Cell Analysis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Cell Type
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. South America Single Cell Analysis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technique
  • 10.2.3. By Cell Type
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Single Cell Analysis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Cell Type
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Single Cell Analysis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Cell Type
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Single Cell Analysis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Cell Type
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Single Cell Analysis Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Qiagen N.V.
• 15.3. Danaher Corporation
• 15.4. Becton, Dickinson and Company.
• 15.5. Merck KGaA
• 15.6. 10X Genomics
• 15.7. Takara Bio Inc.
• 15.8. Standard BioTools Inc.
• 15.9. Bio-Rad Laboratories Inc.
• 15.10. Illumina Inc.

16. Strategic Recommendations

17. About Us & Disclaimer